Searched for
ANTIBIOTIC DRUG DISCOVERY
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
Scientists have found a powerful hidden antibiotic, and they are stunned by its discoveryScientists have discovered a potent new antibiotic, pre-methylenomycin C lactone, within a well-studied bacterium, Streptomyces coelicolor....
Artificial Intelligence designs two potential antibiotics to combat drug-Resistant Gonorrhoea and MRSAResearchers have used AI to design two promising antibiotics that are helpful in combating drug-resistant bacteria, including gonorrhoea an...
Wockhardt exits US generics biz to focus on drug discoveryWockhardt is set to exit its loss-making US generics business to prioritize innovation, focusing on new antibiotic drug discovery and its b...
Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Co...
Drug discovery gaps can only be filled by returning to the root of medicine, says this scientistNatural products from microbes and plants are the biggest resource for drug discovery.
Wockhardt rallies after revival plan gets a boost from drug nodInvestors cheered the news, sending Wockhardt’s shares up by 5.7 per cent on the BSE on Thursday.
This type of onion can help fight drug-resistant tuberculosisWhen a patient has a bacterial TB infection, they may be prescribed an antibiotic.
World running out of antibiotics: WHOPharmaceutical companies and researchers must urgently focus on new antibiotics against certain types of extremely serious infections, said...
Reckless antibiotic use to treat common infections like UTI can be deadlyUTI is one of the most common bacterial infections. It is more common in women than men.
Now smaller firms developing antibiotics but will society, politicians accept high prices?As a woman dies in the US from a superbug infection likely caught in India, four domestic companies are taking up the cudgels in the area o...
Wockhardt gets QIDP status for new antibiotic product from FDAQIDP status is granted to drugs identified by Centre for Disease Control, US, that act against pathogens which have a high degree of unmet ...
New method developed to reduce antibiotic resistanceA novel mathematical method inspired by the Darwinian evolution has been developed to reduce the development of antibiotic-resistant bacter...
Why Indian startups like Bugworks, Vitas Pharma have entered the field of drug discoveryAcross geographies, big pharmaceutical companies seem to have stepped back from research and development (R&D) for new drug discovery in th...
Cadila Pharma, Helperby sign licensing deal on antibiotic drug resistanceDescribed as the most important innovation in the discovery of antibiotics since Alexander Fleming's original breakthrough more than 80 yea...
Cadila Pharmaceuticals Ltd & Helperby sign licensing deal on antibiotic drug resistanceHelperby will supply Cadila Pharma with Antibiotic Resistance Breakers whilst Cadila will develop the combinations with old antibiotics.
- 53% Indians take antibiotics without prescription: WHO
Raising concerns over drug resistance, a new study has revealed that 53 per cent Indians take antibiotics without a doctor's prescription.